company-logo

Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma. Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.

Century Therapeutics Dividend Announcement

Century Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Century Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Century Therapeutics Dividend History

Century Therapeutics Dividend Yield

Century Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Century Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Century Therapeutics Financial Ratios

P/E ratio-0.85
PEG ratio0.19
P/B ratio0.56
ROE-66.58%
Payout ratio0.00%
Current ratio10.39
Quick ratio10.39
Cash Ratio2.65

Century Therapeutics Dividend FAQ

Does Century Therapeutics stock pay dividends?
Century Therapeutics does not currently pay dividends to its shareholders.
Has Century Therapeutics ever paid a dividend?
No, Century Therapeutics has no a history of paying dividends to its shareholders. Century Therapeutics is not known for its dividend payments.
Why doesn't Century Therapeutics pay dividends?
There are several potential reasons why Century Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Century Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Century Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Century Therapeutics a dividend aristocrat?
Century Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Century Therapeutics a dividend king?
Century Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Century Therapeutics a dividend stock?
No, Century Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Century Therapeutics stocks?
To buy Century Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Century Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.